Welcome to our dedicated page for SMED news (Ticker: SMED), a resource for investors and traders seeking the latest updates and insights on SMED stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect SMED's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of SMED's position in the market.
Sharps Compliance Corp. (NASDAQ: SMED) announced the appointment of Pat Mulloy II to its Board of Directors. With over 20 years in the senior housing and long-term care sector, Mulloy previously served as CEO of Elmcroft Senior Living and Atria Senior Living. His extensive leadership experience is expected to provide valuable insights as Sharps aims to expand its offerings in the long-term care market. CEO David P. Tusa stressed the opportunities for growth as the company enhances its services in medical waste management for senior living communities.
Sharps Compliance Corp. (NASDAQ: SMED) reported a 17% increase in Q2 revenue, reaching $17.0 million, compared to $14.6 million last year. Customer billings rose 24% to $18.5 million, driven by growth in COVID-19 related mailback orders and route-based services. Net income for the quarter was $1.2 million (or $0.07/share), up from $1.0 million ($0.06/share) a year earlier. The company now anticipates $15 million in COVID-19 related advance mailback orders for the March quarter, up from a previous estimate of $10 million. Gross margin decreased to 33% from 34%.
Sharps Compliance Corp. (NASDAQ: SMED) will announce its second quarter 2021 financial results on January 28, 2021. The release will precede a conference call at 11:00 a.m. ET, discussing financial performance, market initiatives, and business strategy. Investors can access the call through specific domestic and international phone lines, with a replay available through February 27, 2021. Sharps Compliance specializes in managing regulated medical waste and unused medications, servicing healthcare, long-term care, and retail pharmacy sectors.
Sharps Compliance Corp. (SMED) has completed significant infrastructure projects that have nearly tripled its treatment capacity, enhancing its ability to manage medical and hazardous waste in response to increased demand due to the COVID-19 pandemic and flu season. As of January 1, 2021, the company holds $10 million in advance mailback orders poised for shipment in March 2021, alongside a robust inventory of 300,000 mailback units. Sharps Compliance anticipates continued strong order activity and has expanded its line of credit to support growth initiatives.
Sharps Compliance Corp. (SMED) reported a 3% decline in first-quarter revenue to $13.2 million, attributed to altered customer ordering patterns for flu-related mailback orders. However, Long-Term Care and Pharmaceutical Manufacturer billings surged 110% and 26%, respectively. The company also expanded its medical waste processing capacity in Pennsylvania from 18 million to 27 million pounds per year. Despite experiencing an operating loss of $0.4 million, recovery in the route-based business and a robust pipeline for field sales opportunities indicate a promising outlook for the December quarter.
Sharps Compliance Corp. (Nasdaq: SMED) will release its first quarter 2021 results on October 27, 2020. The financial results, covering the period ended September 30, 2020, will be discussed during a conference call at 11:00 a.m. ET. The company provides comprehensive waste management services, primarily for healthcare facilities and pharmaceutical manufacturers, focusing on safe disposal solutions. Sharps Compliance aims to educate customers and scale its business while navigating industry risks and compliance challenges.
Sharps Compliance Corp. (Nasdaq: SMED) has announced that CEO David P. Tusa will participate in the Lake Street Best Ideas Growth Conference on September 17, 2020. This virtual event allows Mr. Tusa to engage in one-on-one and small group meetings via teleconference throughout the day.
Based in Houston, Texas, Sharps Compliance specializes in comprehensive waste management services, catering to healthcare and pharmaceutical sectors, among others. Their flagship product, Sharps Recovery System, addresses the containment and disposal of medical waste.
Sharps Compliance Corp. (Nasdaq: SMED) has announced that CEO David P. Tusa will participate in Barrington Research’s 13th Annual Fall Investment Conference on September 9, 2020. This virtual event will allow Mr. Tusa to engage in one-on-one and small group meetings via teleconference throughout the day.
Sharps Compliance is a leading provider of waste management services, including medical and hazardous waste. The company offers innovative solutions like the Sharps Recovery System and medication disposal options, serving various healthcare sectors across 32 states.
Sharps Compliance Corp. (NASDAQ: SMED) reported a 3% revenue increase to $12.6 million in Q4 2020, driven by significant growth in their key markets. Customer billings rose 6% to $13.5 million, with assisted living billings up 96%. Gross margins improved to 33%. The company experienced a $1.7 million income tax benefit, boosting net income to $2.2 million, or $0.13 per share, compared to $0.5 million, or $0.03 per share, a year ago. Sharps is expanding its waste processing capacity and has increased inventory in anticipation of heightened flu and COVID-19 immunization activities.
Sharps Compliance Corp. (Nasdaq: SMED) will release its fourth quarter 2020 results on August 19, 2020, before market open. A conference call is scheduled for 11:00 a.m. ET to discuss financial results, market initiatives, and business strategy. The company provides comprehensive waste management services, including medical and pharmaceutical waste solutions. Its flagship product is the Sharps Recovery System, enhancing the disposal process. Investors can listen to the conference call by dialing specific numbers for domestic and international access.
FAQ
What is the market cap of SMED (SMED)?
